1421 related items for PubMed ID: 16898486
21. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
[Abstract] [Full Text] [Related]
22. Tacrolimus can induce remission in cyclosporine and mycophenolate mofetil resistant pediatric onset nephrotic syndrome.
Ahmed HM.
Iran J Kidney Dis; 2019 Sep; 13(5):322-327. PubMed ID: 31705749
[Abstract] [Full Text] [Related]
23. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
Tasanarong A, Thitiarchakul S.
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
[Abstract] [Full Text] [Related]
24. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome.
Li Z, Duan C, He J, Wu T, Xun M, Zhang Y, Yin Y.
Pediatr Nephrol; 2010 May; 25(5):883-8. PubMed ID: 19953275
[Abstract] [Full Text] [Related]
25. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
[Abstract] [Full Text] [Related]
26. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
[Abstract] [Full Text] [Related]
27. [Use of Cyclosporine A and new immunosuppressive drugs in the therapy of glomerulonephritis].
Dudzik B, Kaczmarczyk I, Radziszewski A, Sułowicz W.
Przegl Lek; 2001 Apr 23; 58(7-8):798-804. PubMed ID: 11769390
[Abstract] [Full Text] [Related]
28. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R.
Clin J Am Soc Nephrol; 2006 Nov 23; 1(6):1173-8. PubMed ID: 17699344
[Abstract] [Full Text] [Related]
29. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.
Pediatr Nephrol; 2015 Apr 23; 30(4):687-91. PubMed ID: 25576066
[Abstract] [Full Text] [Related]
30. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 23; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
31. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
[Abstract] [Full Text] [Related]
32. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
33. Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome.
de Mello VR, Rodrigues MT, Mastrocinque TH, Martins SP, de Andrade OV, Guidoni EB, Scheffer DK, Martini Filho D, Toporovski J, Benini V.
Pediatr Nephrol; 2010 Mar 01; 25(3):453-60. PubMed ID: 19937060
[Abstract] [Full Text] [Related]
34. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
El-Husseini A, El-Basuony F, Mahmoud I, Donia A, Sheashaa H, Sabry A, Hassan N, Sayed-Ahmad N, Sobh M.
Eur J Clin Pharmacol; 2006 Jan 01; 62(1):3-8. PubMed ID: 16374637
[Abstract] [Full Text] [Related]
35. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
[Abstract] [Full Text] [Related]
36. Combination treatment with corticosteroid, cyclosporine A, and mycophenolate in refractory nephrotic syndrome.
Jang HR, Jung HW, Lee YJ, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG.
Clin Nephrol; 2011 Jun 10; 75(6):511-7. PubMed ID: 21612754
[Abstract] [Full Text] [Related]
37. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.
Ulinski T, Aoun B.
Curr Med Chem; 2010 Jun 10; 17(9):847-53. PubMed ID: 20156172
[Abstract] [Full Text] [Related]
38. Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.
Al-Akash S, Al-Makdama A.
Ann Saudi Med; 2005 Jun 10; 25(5):380-4. PubMed ID: 16270759
[Abstract] [Full Text] [Related]
39. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF.
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 10; 10(5):575-8. PubMed ID: 18947472
[Abstract] [Full Text] [Related]
40. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 10; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
